Midea Healthcare is the medical and healthcare brand under Midea Group and one of its key growth segments. Leveraging technology to empower healthcare, Midea Healthcare focuses on two core areas: clinical medicine and technology (frontline medical services) and construction and operation (back-end hospital infrastructure).
In the clinical medicine and technology segment, WanDong Medical, KUKA, and Midea Biomedical safeguard life through technology—delivering diagnostic and treatment services for departments such as radiology, operating rooms, medical technology centres, and outpatient pharmacies. We aim to make advanced treatments more accessible and help alleviate medical resource shortages in small and mid-sized hospitals through remote capabilities.
In the construction and operation segment, Swisslog Healthcare and Midea Building Technologies improve operational efficiency with smart hospital top-level design—integrating equipment supply and engineering services into outpatient clinics, pharmacies, inpatient wards, and command centres. We enable hospitals with the ability to perceive, think, and act.
To date, Midea Healthcare has served 16 of China's top 20 hospitals and 18 of the top 20 hospitals in the United States. Globally, we collaborate with over 100,000 hospitals and provide diagnostic recommendations to more than 7,000 hospitals in China—using the power of technology to Respect Every Second of Life.
RESPECT EVERY SECOND OF LIFE
5+2+X Technology Strategy
To accelerate the development of new quality productive forces in China’s healthcare sector through technology leadership, Midea Healthcare officially launched its 5+2+X Technology Strategy at the “For More · For One” Strategy Upgrade Conference during the 89th China International Medical Equipment Fair (CMEF) on 11 April 2024.
The 5+2+X Technology Strategy refers to the synergistic innovation across five medical business units, two central research platforms—Midea Central Research Institute (including the Medical Equipment Research Institute) and Midea AI Research Institute—and their focus on core, forward-looking, and shared technologies. The strategy introduces demand-driven, digitally intelligent multi-category products and multi-scenario application solutions.
By strengthening innovation through talent, systems, and investment, and attracting world-class experts, Midea aims to fast-track breakthroughs in critical technologies and new product innovations, advancing the medical industry from "follower" to "leader" in technology-driven transformation.
The strategy places particular emphasis on the integration of AI and medical technologies. For example, Midea’s CT and MRI divisions will collaborate with AI teams to combine general-purpose AI with imaging hardware physics, delivering superior clinical outcomes.
At the same time, Midea Healthcare will continue to drive breakthroughs in:
Next-generation CT
Next-generation MRI
Hospital-adapted imaging AI
Multi-category product innovations and applications
Key enabling technologies
This technology-led approach will focus on developing core capabilities in CT and MRI innovation. In MRI, for instance, Midea is advancing both full-system development and in-house R&D of core components, gaining command of vertically integrated core technologies to support agile and efficient product innovation.
Milestones
28 June 2024
Backed by Midea’s investment, Heyou Hospital officially opened in Beijiao, Shunde District, Foshan City, marking a new chapter in medical services. As one of China’s representative smart, low-carbon, and high-efficiency hospitals, Heyou Hospital works in close collaboration with Midea Healthcare, introducing a wide range of advanced solutions including instant pharmaceutical delivery, precision imaging, intelligent infusion, and fall prevention, along with infant anti-theft, ICU anti-disconnection, and more—embodying the commitment to Respect Every Second of Life through Technology.
11 April 2024
At the 89th China International Medical Equipment Fair (CMEF), Midea Healthcare announced its 5+2+X Technology Strategy, focusing on core technologies and key component R&D across the healthcare sector. The new AIIO solution was also unveiled, enabling full-process connectivity and driving intelligence, digitalisation, and synergy across the medical landscape.
17 June 2023
At the 24th China Hospital Construction Conference (CHCC2023), Midea Building Technologies and Swisslog Healthcare jointly launched two major systems: the LIFE2.0 Smart Hospital Solution under the concept of “Large Platform, Small Scenarios” and the in-hospital logistics and sorting system, revealing the circulatory lifeline of smart hospitals.
13 May 2023
At the 87th CMEF (Spring Edition), Midea Healthcare debuted five new products under the theme The Next One in healthcare.
12 December 2022Midea Healthcare released its 2022 annual practice report under the theme Respect Every Second of Life.
July 2022
At the 23rd CHCC, Midea Healthcare launched five key business scenarios and officially released its brand mission: Respect Every Second of Life.
27 June 2024
Midea Building Technologies, under Midea Healthcare, published the HEST Blue Book on Smart Hospital Construction. The publication outlines a multidimensional framework for evaluating and evolving smart hospitals, drawing from Humanism, Economy, Society, and Technology.
2021
Midea acquired a controlling stake in WanDong Medical with an investment exceeding RMB 4 billion. This strategic move completed Midea’s comprehensive healthcare blueprint, encompassing KUKA, WanDong, Swisslog Healthcare, and its own Midea Biomedical and Midea Building Technologies, forming a unified flagship team.
2018
The China operations of Swisslog Healthcare were integrated into Midea-KUKA Joint Venture, with Midea Group and Swisslog Healthcare each holding 50% equity in Shanghai Swisslog Healthcare Technology Co., Ltd., driving forward automation in hospital logistics and pharmacy systems.
2015
Midea Group acquired a 10.2% stake in global robotics leader KUKA through open-market investment, becoming its second-largest shareholder. Over the next seven years, Midea invested a total of RMB 30 billion to fully acquire and privatise KUKA.
Honours & Awards
2023
At the 5th China Medical Innovation Summit, Midea Healthcare’s Digital Operating Theatre Solution received the Golden Ruyi Award.
At the 20th People's Ingenuity Awards, Midea Healthcare was honoured with the Brand of Ingenuity Award.
2022
At the CHCC Hospital Construction Awards, Midea Building Technologies was named one of the Top 10 Building Equipment Suppliers, receiving the 2022 CHCC Hospital Construction Award.
•WanDong Medical received numerous accolades, including:
“Beijing Brand Product”
“G20 Industry Leading Enterprise”
“Beijing Top 100 Independent Innovation Pilot Enterprises”
“Top 10 After-Sales Service Providers Nationwide”
“Beijing Science & Technology Third Prize”
“Outstanding National Medical Equipment Brand”
“Beijing Trusted Enterprise”
“Leading Brand in China’s Medical Device Industry”
•Swisslog Healthcare, under Midea Healthcare, was named a Specialised and Innovative SME in Shanghai by the Shanghai Municipal Commission of Economy and Informatization.
•Midea Biomedical’s products Medical ‘Leader’ Refrigerator and Medical ‘Leader’ Low Temperature Freezer were recognised as Enterprise Standard “Leader” models.
The MD-86L568 Medical Low Temperature Freezer received official “Leader” Series Certification.
•At the 2nd People’s Health Conference hosted by People’s Daily Online, Midea Healthcare was recognised for “Outstanding Practice in Health Innovation 2022”.